Strengthening R&D
"To support formulation development, we have invested in
infrastructure and developed in-house capabilities. We have
used several tools to characterize the physicochemical
properties of molecules to ensure they meet FDA
requirements.
Arion Group believes that Research & Development is the growth engine for
its foray into the regulated and semi regulated markets. All R&D initiatives
are guided by the organizational philosophy of providing affordable yet high
quality medicines for health care and wellness. "
OUR PURPOSE
Enriching Lives, that’s not only our prime priority, it is our only priority!
Making a difference to our patients’ lives is our unwavering commitment. To
ensure this, our core strategy is to find the best collaborative solution for the
development of each product.
Arion Group work persistently towards the production of apex quality generic
products, branded generics, specialty products and nutraceuticals, which are
marketed in India as well as globally.
We forayed into the R&D territory back in the year 2017. Our first R&D
development & which is equipped with a wide range of state-of-the-art
equipment.
Our research strategy and implementation &commands a strong expertise
and hold rich experience in chemistry, analytical techniques, dosage forms
and global law. This helps us in furnishing high-quality generic versions of
such products at reasonable costs.
Our R&D centre has been audited and approved by international regulatory
authorities.
